New Technology– category –
-
Allogene Therapeutics’ Off-the-Shelf CAR-T Cema-cel Achieves 58.3% MRD Negativity in ALPHA3 Phase 2 LBCL Trial, Securing FDA RMAT and Fast Track Designations
Allogene Therapeutics, Inc. (Press Release) USA Overview Allogene Therapeutics announced strong Q2 2026 results, highlighting that its off-the-shelf CAR T-cell therapy, cema-cel, achieved a robust 58.3% minimal residual disease (MRD) neg... -
NIH-Funded Team Discovers Miniaturized Al3Cas12f CRISPR Enzyme, Dramatically Enhancing In Vivo Precision Delivery and Solving a Major Gene Therapy Bottleneck
National Institutes of Health (NIH) (News Release) USA Overview An NIH-funded research team has discovered an improved CRISPR gene-editing system enabling precise in vivo gene delivery. This breakthrough involves identifying the naturall... -
USC Viterbi Engineers Develop ‘SHIFTERS’ Strategy to Enhance CAR T-Cell Efficacy Against Solid Tumors Using Hypoxia and Focused Ultrasound for Inducible CD19 Expression
Bioengineer.org USA Overview Researchers at the USC Viterbi School of Engineering have developed 'SHIFTERS,' a novel strategy to boost CAR T-cell efficacy against solid tumors. This innovative approach leverages tumor hypoxia and focused... -
MD Anderson Researchers Identify Immature NK Cell Subpopulation in Donor Umbilical Cord Blood That Compromises CAR-NK Cell Therapy Antitumor Activity
Mirage News USA Overview Researchers at MD Anderson have discovered that a specific subpopulation of immature natural killer (NK) cells found in donor umbilical cord blood can diminish the antitumor activity of chimeric antigen receptor ... -
Challenges in Rapid AI Tool Development and Deployment in Clinics: Data Privacy, Algorithmic Bias, and Regulatory Delays
Facebook (STAT News) USA Overview The rapid development and deployment of clinical AI tools raise significant challenges and ethical concerns, including data privacy risks, algorithmic bias, and the 'black box' nature of many AI models. ... -
Corma Raises $60 Million Seed Funding to Build First Defensive Cybersecurity AI Foundation Model
Dealroom.co Unknown Overview Corma, a frontier AI lab focusing on defensive cybersecurity, secured $60 million in seed funding to build the first foundation model purpose-built for defensive cybersecurity. The company argues that existin... -
Liquid AI Debuts LFM2.5-2.6B: A Powerful AI Agent Model Running on Raspberry Pi Without Cloud or GPUs
VentureBeat USA Overview AI startup Liquid AI debuted LFM2.5-2.6B, a new open-weight language model designed for agentic workloads that can run on local hardware without cloud inference or GPUs. This model enables edge AI applications on... -
Aureka Biotechnologies Secures $100 Million Series B to Accelerate AI Drug Discovery Biological Foundation Models, Nearing $200 Million Total Funding
Under30CEO USA Overview AI-native TechBio company Aureka Biotechnologies closed a $100 million Series B funding round, bringing its total raised to nearly $200 million, to build a biological world model for drug discovery. The funding wi... -
Hims & Hers Launches AI-Powered App, While Novo Nordisk Partners with H1 for AI-Driven Clinical Development
Fierce Healthcare USA Overview Hims & Hers has launched a new AI-powered care experience for Hers patients, integrating personalized support, provider oversight, and real-time progress tracking. Additionally, AI-powered platform H1 a... -
Novo Nordisk Partners with Amazon Web Services to Drive AI Drug Discovery
PharmExec USA Overview Novo Nordisk has partnered with Amazon Web Services (AWS) to leverage AI for drug discovery, utilizing services like Amazon Bio Discovery and Amazon Bedrock to identify drug targets and design therapies. This colla...
